Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

New aspects of the infection mechanisms of Bacillus anthracis.

Zakowska D, Bartoszcze M, Niemcewicz M, Bielawska-Drózd A, Kocik J.

Ann Agric Environ Med. 2012;19(4):613-8. Review.

2.

Activity of the Bacillus anthracis 20 kDa protective antigen component.

Hammamieh R, Ribot WJ, Abshire TG, Jett M, Ezzell J.

BMC Infect Dis. 2008 Sep 22;8:124. doi: 10.1186/1471-2334-8-124.

3.

Anthrax toxin.

Bhatnagar R, Batra S.

Crit Rev Microbiol. 2001;27(3):167-200. Review.

PMID:
11596878
4.

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID:
17005989
5.

Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.

Cote CK, Welkos SL.

Toxins (Basel). 2015 Aug 17;7(8):3167-78. doi: 10.3390/toxins7083167. Review.

6.

Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.

Hahn UK, Alex M, Czerny CP, Böhm R, Beyer W.

Int J Med Microbiol. 2004 Jul;294(1):35-44.

PMID:
15293452
7.

Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis.

Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, Hoover TA, Young HA, Anderson AO, Bavari S.

J Immunol. 2005 May 1;174(9):5545-52.

8.

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.

Microb Pathog. 2005 May-Jun;38(5-6):209-25. Epub 2005 Apr 22.

PMID:
15925272
9.

Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.

Brossier F, Lévy M, Landier A, Lafaye P, Mock M.

Infect Immun. 2004 Nov;72(11):6313-7.

10.

An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.

Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.

Vaccine. 2006 May 1;24(18):3953-63. Epub 2006 Feb 28.

PMID:
16530302
11.

A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.

Moayeri M, Leysath CE, Tremblay JM, Vrentas C, Crown D, Leppla SH, Shoemaker CB.

J Biol Chem. 2015 Mar 6;290(10):6584-95. doi: 10.1074/jbc.M114.627943. Epub 2015 Jan 6.

12.

Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.

Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.

Vaccine. 2005 Dec 1;23(48-49):5688-97. Epub 2005 Feb 5.

PMID:
16039760
13.

Role of toxin functional domains in anthrax pathogenesis.

Brossier F, Weber-Levy M, Mock M, Sirard JC.

Infect Immun. 2000 Apr;68(4):1781-6.

14.

Cytokine response to infection with Bacillus anthracis spores.

Pickering AK, Osorio M, Lee GM, Grippe VK, Bray M, Merkel TJ.

Infect Immun. 2004 Nov;72(11):6382-9.

15.

Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.

Sinha K, Bhatnagar R.

Med Microbiol Immunol. 2013 Apr;202(2):153-65. doi: 10.1007/s00430-012-0280-z. Epub 2012 Dec 21.

PMID:
23263010
16.

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.

Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.

Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13601-6. Epub 2004 Sep 1.

17.

The germination-specific lytic enzymes SleB, CwlJ1, and CwlJ2 each contribute to Bacillus anthracis spore germination and virulence.

Giebel JD, Carr KA, Anderson EC, Hanna PC.

J Bacteriol. 2009 Sep;191(18):5569-76. doi: 10.1128/JB.00408-09. Epub 2009 Jul 6.

18.

Protective immunity induced by Bacillus anthracis toxin-deficient strains.

Pezard C, Weber M, Sirard JC, Berche P, Mock M.

Infect Immun. 1995 Apr;63(4):1369-72.

19.

The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.

Levy H, Weiss S, Altboum Z, Schlomovitz J, Rothschild N, Glinert I, Sittner A, Kobiler D.

Microb Pathog. 2012 Jan;52(1):55-60. doi: 10.1016/j.micpath.2011.10.002. Epub 2011 Oct 17.

PMID:
22020310
20.

Where and how do anthrax toxins exit endosomes to intoxicate host cells?

Puhar A, Montecucco C.

Trends Microbiol. 2007 Nov;15(11):477-82. Epub 2007 Nov 5.

PMID:
17983750

Supplemental Content

Support Center